Exact Mass: 408.1644914
Exact Mass Matches: 408.1644914
Found 335 metabolites which its exact mass value is equals to given mass value 408.1644914,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Beclometasone
C22H29ClO5 (408.17034140000004)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
Tamsulosin
C20H28N2O5S (408.17188380000005)
Tamsulosin is a selective antagonist at alpha-1A and alpha-1B-adrenoceptors in the prostate, prostatic capsule, prostatic urethra, and bladder neck. At least three discrete alpha1-adrenoceptor subtypes have been identified: alpha-1A, alpha-1B and alpha-1D; their distribution differs between human organs and tissue. Approximately 70\\\% of the alpha1-receptors in human prostate are of the alpha-1A subtype. Blockage of these receptors causes relaxation of smooth muscles in the bladder neck and prostate. G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tamsulosin ((R)-(-)-YM12617 free base) is an inhibitor of α1-adrenergic receptor. Tamsulosin is used for the research of prostatic hyperplasia. Tamsulosin attenuates abdominal aortic aneurysm growth in animal models[1].
MK-329
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist Same as: D02693 Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1].
9-Hydroxycalabaxanthone
9-Hydroxycalabaxanthone is found in fruits. 9-Hydroxycalabaxanthone is a constituent of Garcinia mangostana (mangosteen)
Garcimangosone B
Garcimangosone B is found in fruits. Garcimangosone B is a constituent of the dry fruit hulls of Garcinia mangostana (mangosteen). Constituent of the dry fruit hulls of Garcinia mangostana (mangosteen). Garcimangosone B is found in fruits.
Bakkenolide D
C21H28O6S (408.16065080000004)
Constituent of Petasites japonicus (sweet coltsfoot). Bakkenolide D is found in giant butterbur and green vegetables. Bakkenolide D is found in giant butterbur. Bakkenolide D is a constituent of Petasites japonicus (sweet coltsfoot)
Mammea A/AC cyclo F
Mammea A/AC cyclo F is found in fruits. Mammea A/AC cyclo F is a constituent of Mammea americana (mamey). Constituent of Mammea americana (mamey). Mammea A/AC cyclo F is found in fruits.
8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one
8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one is found in fruits. 8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one is isolated from Mammea americana (mamey) seeds. Isolated from Mammea americana (mamey) seeds. 8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one is found in fruits.
Alclometasone
C22H29ClO5 (408.17034140000004)
Alclometasone is only found in individuals that have used or taken this drug. It is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent. [Wikipedia]The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Alclometasone initially binds the corticosteroid receptor. This complex migrates to the nucleus where it binds to different glucocorticoid response elements on the DNA. This in turn enhances and represses various genes, especially those involved in inflammatory pathways. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid
6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid is found in fruits. 6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid is a constituent of the fruit hulls of Garcinia mangostana (mangosteen). Constituent of the fruit hulls of Garcinia mangostana (mangosteen). 6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid is found in fruits.
beclomethasone
C22H29ClO5 (408.17034140000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
Montirelin
5-Benzyl-2-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]-6-methylpyridazin-3-one
N-[4-(Benzylamino)-3-cyanoquinolin-2-yl]-4-methoxybenzamide
Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-
C20H28N2O5S (408.17188380000005)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(butyryl)-6-phenylfurano[2,3-h][1]benzopyran-8-one
OCHROCARPIN E
A furanocoumarin that is 2,3-dihydro-7H-furo[2,3-f]chromen-7-one substituted by a hydroxy group at position 4, a 2-hydroxypropan-2-yl group at position 2, a 2-methylpropanoyl group at position 5 and a phenyl group at position 9. Isolated from the bark of Ochrocarpos punctatus, it exhibits cytotoxicity against the A2780 ovarian cancer cell line.
1,2-Dihydro-5-hydroxy-2- (1-hydroxy-1-methylethyl) -4- (butyryl) -6-phenylfurano [ 2,3-h ] [ 1 ] benzopyran-8-one
1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(isobutyryl)-6-phenylfurano[2,3-h][1]benzopyran-8-one
SSR161421
CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4517; ORIGINAL_PRECURSOR_SCAN_NO 4515 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4524 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4486; ORIGINAL_PRECURSOR_SCAN_NO 4482 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4512; ORIGINAL_PRECURSOR_SCAN_NO 4511 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4511; ORIGINAL_PRECURSOR_SCAN_NO 4509 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4499; ORIGINAL_PRECURSOR_SCAN_NO 4496 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8790; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8826; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8842; ORIGINAL_PRECURSOR_SCAN_NO 8841 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8870; ORIGINAL_PRECURSOR_SCAN_NO 8865 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8884; ORIGINAL_PRECURSOR_SCAN_NO 8882 CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8898; ORIGINAL_PRECURSOR_SCAN_NO 8897 ORIGINAL_PRECURSOR_SCAN_NO 8897; CONFIDENCE standard compound; INTERNAL_ID 631; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8898
(6aS)-6a-methyl-9-(2-methylbutyryl)-3-[(1S*,6S*)-6-methyl-2-oxocyclohex-3-enyl]-6aH-furo[2,3-h]isochromene-6,8-dione|multiformin B
2,2-Dimethyl-5,9-dihydroxy-8-(3-methyl-2-butenyl)-10-methoxy-2H,6H-pyrano[3,2-b]xanthene-6-one
2,2-Dimethyl-5,9-dihydroxy-8-methoxy-12-(3-methyl-2-butenyl)-2H,6H-pyrano[3,2-b]xanthene-6-one
1,5-dihydroxy-3-methoxy-4-(1,1-dimethylprop-2-enyl)-18,18-dimethyl-2H-pyrano[7,6-b]xanthen-9-one|pedunxanthone C
2,3-Dimethoxy-7,8-didehydro-7,16-seco-strychnidin-10,16-dion|2,3-dimethoxy-7,8-didehydro-7,16-seco-strychnidine-10,16-dione
1-[2,4-Dihydroxy-3-(2-hydroxybenzyl)-6-methoxyphenyl]-3-(4-methoxyphenyl)-1-propanone
1-O-(3-methylbut-3-en-1-yl)-6-O-beta-D-xylopyranosyl-beta-D-glucopyranose|nonioside L
C17H28O11 (408.16315380000003)
5-oxobrucine
A monoterpenoid indole alkaloid with formula C23H24N2O5, originallly isolated from the seeds of Strychnos nux-vomica.
Garciniaxanthone F
An organic heteropentacyclic compound that is 6H-furo[3,2-c]xanthen-6-one substituted by hydroxy groups at positions 7 and 10, 2-methoxypropan-2-yl group at position 2 and a 2-methylbut-3-en-2-yl group at position 8. Isolated from the woods of Garcinia subelliptica, it exhibits antioxidant activity.
Bakkenolide D
C21H28O6S (408.16065080000004)
N-(1-Deoxyfructopyranos-1-yl)isoleucylaspartic acid
MLS001333651-01!Dehydroisoandrosterone 3-sulfate sodium salt hydrate1099-87-2
C19H29NaO6S (408.15824540000006)
Ala Asp Phe Gly
Ala Asp Gly Phe
Ala Phe Asp Gly
Ala Phe Gly Asp
Ala Gly Asp Phe
Ala Gly Phe Asp
Ala Met Ser Thr
Ala Met Thr Ser
Ala Ser Met Thr
Ala Ser Thr Met
Ala Thr Met Ser
Ala Thr Ser Met
Cys Ile Ser Ser
Cys Leu Ser Ser
Cys Ser Ile Ser
Cys Ser Leu Ser
Cys Ser Ser Ile
Cys Ser Ser Leu
Cys Ser Thr Val
Cys Ser Val Thr
Cys Thr Ser Val
Cys Thr Val Ser
Cys Val Ser Thr
Cys Val Thr Ser
Asp Ala Phe Gly
Asp Ala Gly Phe
Asp Phe Ala Gly
Asp Phe Gly Ala
Asp Gly Ala Phe
Asp Gly Phe Ala
Glu Phe Gly Gly
Glu Gly Phe Gly
Glu Gly Gly Phe
Phe Ala Asp Gly
Phe Ala Gly Asp
Phe Asp Ala Gly
Phe Asp Gly Ala
Phe Glu Gly Gly
Phe Gly Ala Asp
Phe Gly Asp Ala
Phe Gly Glu Gly
Phe Gly Gly Glu
Gly Ala Asp Phe
Gly Ala Phe Asp
Gly Asp Ala Phe
Gly Asp Phe Ala
Gly Glu Phe Gly
Gly Glu Gly Phe
Gly Phe Ala Asp
Gly Phe Asp Ala
Gly Phe Glu Gly
Gly Phe Gly Glu
Gly Gly Glu Phe
Gly Gly Phe Glu
Gly Met Thr Thr
Gly Thr Met Thr
Gly Thr Thr Met
Ile Cys Ser Ser
Ile Ser Cys Ser
Ile Ser Ser Cys
Leu Cys Ser Ser
Leu Ser Cys Ser
Leu Ser Ser Cys
Met Ala Ser Thr
Met Ala Thr Ser
Met Gly Thr Thr
Met Ser Ala Thr
Met Ser Thr Ala
Met Thr Ala Ser
Met Thr Gly Thr
Met Thr Ser Ala
Met Thr Thr Gly
Ser Ala Met Thr
Ser Ala Thr Met
Ser Cys Ile Ser
Ser Cys Leu Ser
Ser Cys Ser Ile
Ser Cys Ser Leu
Ser Cys Thr Val
Ser Cys Val Thr
Ser Ile Cys Ser
Ser Ile Ser Cys
Ser Leu Cys Ser
Ser Leu Ser Cys
Ser Met Ala Thr
Ser Met Thr Ala
Ser Ser Cys Ile
Ser Ser Cys Leu
Ser Ser Ile Cys
Ser Ser Leu Cys
Ser Thr Ala Met
Ser Thr Cys Val
Ser Thr Met Ala
Ser Thr Val Cys
Ser Val Cys Thr
Ser Val Thr Cys
Thr Ala Met Ser
Thr Ala Ser Met
Thr Cys Ser Val
Thr Cys Val Ser
Thr Gly Met Thr
Thr Gly Thr Met
Thr Met Ala Ser
Thr Met Gly Thr
Thr Met Ser Ala
Thr Met Thr Gly
Thr Ser Ala Met
Thr Ser Cys Val
Thr Ser Met Ala
Thr Ser Val Cys
Thr Thr Gly Met
Thr Thr Met Gly
Thr Val Cys Ser
Thr Val Ser Cys
Val Cys Ser Thr
Val Cys Thr Ser
Val Ser Cys Thr
Val Ser Thr Cys
Val Thr Cys Ser
Val Thr Ser Cys
9-Hydroxycalabaxanthone
Garcimangosone B
6,8-Dihydroxy-1,7-diprenylxanthone-2-carboxylic acid
6,8-Difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid ethyl ester
C19H22F2N4O4 (408.16090360000004)
(2R,3R)-1-CARBOXY-4-IODO-2,3-DIHYDROXYCYCLOHEXA-4,6-DIENE,95
Montirelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76367 - Thyrotropin-Releasing Hormone Analogue D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-[(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxoazepan-1-yl]acetic acid
(1R,2S)-Ethyl 1-amino-2-vinylcyclopropanecarboxylate hemisulfate
2-amino-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoic acid,hydrochloride
C16H29ClN4O4S (408.15979440000007)
11,12-Dihydro-11,12-diphenylindolo[2,3-a]carbazole
Triethylene glycol 4-methylbenzyl ether tosylate
C21H28O6S (408.16065080000004)
(+)-Tamsulosin
C20H28N2O5S (408.17188380000005)
N-[4-(Benzylamino)-3-cyanoquinolin-2-yl]-4-methoxybenzamide
2-(5-butoxy-1-oxo-2-isoquinolinyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide
N-[3-[2-(1-cyclohexenyl)ethylamino]-2-quinoxalinyl]benzenesulfonamide
[1-(1-Methyl-4,5-dioxo-pent-2-enylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester
Alclometasone
C22H29ClO5 (408.17034140000004)
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
10-[3-(4-Methylpiperazin-1-ium-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
C21H25F3N3S+ (408.17211860000003)
Devazepide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1].
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
C22H29ClO5 (408.17034140000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
2-[[3-(2,6-dimethyl-4-morpholinyl)-2-quinoxalinyl]thio]-N-phenylacetamide
2-Cyano-3-{4-[(2,4-dimethyl-phenylcarbamoyl)-methoxy]-3-methoxy-phenyl}-acrylic acid ethyl ester
1-[(2S,3S)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2R,3R)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2S,3R)-6-[1,3-benzodioxol-5-yl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
(Z)-2-cyano-N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-3-naphthalen-2-ylprop-2-enamide
(2S)-2-[(2-aminoacetyl)amino]-N-[2-[2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]ethyldisulfanyl]ethyl]propanamide
Dehydroisoandrosterone 3-sulfate sodium salt hydrate
C19H29NaO6S (408.15824540000006)
Tamsulosin
C20H28N2O5S (408.17188380000005)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tamsulosin ((R)-(-)-YM12617 free base) is an inhibitor of α1-adrenergic receptor. Tamsulosin is used for the research of prostatic hyperplasia. Tamsulosin attenuates abdominal aortic aneurysm growth in animal models[1].
Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-
C20H28N2O5S (408.17188380000005)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
8,9-Dihydro-5-hydroxy-8-(1-hydroxy-1-methylethyl)-6-(2-methyl-1-oxopropyl)-4-phenyl-2H-furo[2,3-h]-1-benzopyran-2-one
LY2444296
LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ～1 nM. LY2444296 exhibits anti-anxiety like effects[1][2].
RBC10
RBC10 is an anti-cancer agent. RBC10 inhibits the binding of Ral to its effector RALBP1. RBC10 also inhibits Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines[1].
methyl (2r)-4-hydroxy-2-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-5-oxo-3-phenylfuran-2-carboxylate
methyl 4-hydroxy-2-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-5-oxo-3-phenylfuran-2-carboxylate
methyl 6,7-dimethoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,18-heptaene-19-carboxylate
5,9-dihydroxy-10-methoxy-2,2-dimethyl-12-(2-methylbut-3-en-2-yl)-1,11-dioxatetracen-6-one
methyl (1r,9r,10r,12r)-4-methoxy-15,20-dioxo-8,16-diazahexacyclo[8.8.2.2⁹,¹².0¹,⁹.0²,⁷.0¹²,¹⁶]docosa-2,4,6,13-tetraene-8-carboxylate
3',6'-dimethyl-1h,1''h-dispiro[2-benzoxepine-3,2'-[1,4]dioxane-5',3''-[2]benzoxepine]-9,9''-diol
3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
5,9-dihydroxy-8-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
1,5-dihydroxy-3-methoxy-6',6'-dimethyl-2h-pyrano(2',3':6,7)-4-(3-methylbut-2-enyl)xanthone
{"Ingredient_id": "HBIN001659","Ingredient_name": "1,5-dihydroxy-3-methoxy-6',6'-dimethyl-2h-pyrano(2',3':6,7)-4-(3-methylbut-2-enyl)xanthone","Alias": "NA","Ingredient_formula": "C24H24O6","Ingredient_Smile": "CC(=CCC1=C(C=C(C2=C1OC3=C(C4=C(C=CC(O4)(C)C)C=C3C2=O)O)O)OC)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5973","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anhydromangostanol*
{"Ingredient_id": "HBIN016170","Ingredient_name": "anhydromangostanol*","Alias": "NA","Ingredient_formula": "C24H24O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1277","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bakkenolide d
C21H28O6S (408.16065080000004)
{"Ingredient_id": "HBIN017535","Ingredient_name": "bakkenolide d","Alias": "NA","Ingredient_formula": "C21H28O6S","Ingredient_Smile": "CC1CCC(C2C1(CC3(C2OC(=O)C)C(=C)COC3=O)C)OC(=O)C=CSC","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2120","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137705098","DrugBank_id": "NA"}
4-[2-(13-bromo-6,10-dimethyltrideca-3,5-dien-12-yn-2-yl)cyclopropyl]butanoic acid
(8s)-5-hydroxy-8-(2-hydroxypropan-2-yl)-6-(2-methylpropanoyl)-4-phenyl-8h,9h-furo[2,3-h]chromen-2-one
2-[(1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}butylidene)amino]pentanedioic acid
(2r,3ar,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(2r)-4-hydroxy-2-(2-hydroxypropan-2-yl)-5-(2-methylpropanoyl)-9-phenyl-2h,3h-furo[2,3-f]chromen-7-one
5,8-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
6-butanoyl-5,7-dihydroxy-8-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-4-phenylchromen-2-one
5-hydroxy-4-methoxy-16,16-dimethyl-13-(3-methylbut-2-en-1-yl)-2,9,15-trioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(11),3(8),4,6,12,14(19),17-heptaen-10-one
5,7-dihydroxy-6-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-8-(2-methylpropanoyl)-4-phenylchromen-2-one
(2s)-2-{[(2s)-2-{[(2r)-2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid
(2s)-2-{[(2s,3s)-1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}pentylidene]amino}butanedioic acid
(8s)-6-butanoyl-5-hydroxy-8-(2-hydroxypropan-2-yl)-4-phenyl-8h,9h-furo[2,3-h]chromen-2-one
(2s)-2-{[(2s)-1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}butylidene]amino}pentanedioic acid
8-butanoyl-5,7-dihydroxy-6-(2-hydroxy-3-methylbut-3-en-1-yl)-4-phenylchromen-2-one
5,9-dihydroxy-10-methoxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
(2r,3r,3ar,4s,7s,7ar)-4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl (2z)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2z)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
4,8-dihydroxy-7-methoxy-6-(3-methylbut-2-en-1-yl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-b]xanthen-5-one
(2s)-4,8-dihydroxy-7-methoxy-6-(3-methylbut-2-en-1-yl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-b]xanthen-5-one
5,10-dihydroxy-9-methoxy-2,2-dimethyl-12-(2-methylbut-3-en-2-yl)-1,11-dioxatetracen-6-one
5,9-dihydroxy-10-methoxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
2-{16-methyl-20-oxo-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-11-yl}-2-oxoethyl acetate
(2r,3r,3ar,4s,7s,7ar)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2e)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
8-butanoyl-5,7-dihydroxy-6-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-4-phenylchromen-2-one
2-[(16r,17s,18r)-16-methyl-20-oxo-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-11-yl]-2-oxoethyl acetate
3,4',6-trimethoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2-yl acetate
(1r,6r,13r)-13-hydroxy-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
4-[(1r,2r)-2-[(2s,3e,5e,10r)-13-bromo-6,10-dimethyltrideca-3,5-dien-12-yn-2-yl]cyclopropyl]butanoic acid
13-hydroxy-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
(7s,8s)-5-chloro-7-hydroxy-8-[(3s,4s)-4-hydroxy-3-methyl-2-oxopentyl]-7-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-8h-isochromen-6-one
C22H29ClO5 (408.17034140000004)
(8r)-6-butanoyl-5-hydroxy-8-(2-hydroxypropan-2-yl)-4-phenyl-8h,9h-furo[2,3-h]chromen-2-one
2,4',6-trimethoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-3-yl acetate
6,12-dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-1,10-dioxatetraphen-5-one
(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydrocyclopenta[c]pyran-7-yl acetate
C17H28O11 (408.16315380000003)
6-butanoyl-5,7-dihydroxy-8-(2-hydroxy-3-methylbut-3-en-1-yl)-4-phenylchromen-2-one
4-hydroxy-6-[4-hydroxy-3-(2-methylprop-1-en-1-yl)phenyl]-2-(2-hydroxypropan-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(1s,6r,8r,12r,13s,23r)-16-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-11(25),15(20),16,18-tetraene-21,24-dione
22-hydroxy-10-methoxy-7,7,18,18-tetramethyl-8,13,17-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,9,11,14,16(21),19-heptaen-2-one
4-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)
5,9-dihydroxy-8-methoxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
5,7-dihydroxy-8-(2-hydroxy-3-methylbut-3-en-1-yl)-6-(2-methylpropanoyl)-4-phenylchromen-2-one
18-acetyl 18-methyl (1s,10s,12r,13e)-13-ethylidene-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6,8-tetraene-18,18-dicarboxylate
(2s)-4-hydroxy-2-(2-hydroxypropan-2-yl)-5-(2-methylpropanoyl)-9-phenyl-2h,3h-furo[2,3-f]chromen-7-one
(6as)-6a-methyl-3-[(1s,6s)-6-methyl-2-oxocyclohex-3-en-1-yl]-9-(2-methylbutanoyl)furo[2,3-h]isochromene-6,8-dione
(6as)-6a-methyl-3-[(1r,6r)-6-methyl-2-oxocyclohex-3-en-1-yl]-9-[(2r)-2-methylbutanoyl]furo[2,3-h]isochromene-6,8-dione
7,12-dihydroxy-9-methoxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
2-[(1-hydroxy-3-methyl-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}pentylidene)amino]butanedioic acid
6a-methyl-3-(6-methyl-2-oxocyclohex-3-en-1-yl)-9-(2-methylbutanoyl)furo[2,3-h]isochromene-6,8-dione
(2s)-4-hydroxy-6-[4-hydroxy-3-(2-methylprop-1-en-1-yl)phenyl]-2-(2-hydroxypropan-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(2s,3s,3as,4r,7r,7as)-3-(acetyloxy)-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-4-yl (2e)-3-(methylsulfanyl)prop-2-enoate
C21H28O6S (408.16065080000004)